Ruixuan Jia

Title: Ruixuan Jia: Innovator in Gene Therapy

Introduction

Ruixuan Jia is a prominent inventor based in Beijing, China. He has made significant contributions to the field of gene therapy, particularly in the treatment of retinal diseases. His innovative work has led to the development of a unique vector that holds promise for treating Bietti's crystalline dystrophy.

Latest Patents

Ruixuan Jia holds 1 patent for his invention titled "Vector and method for treating Bietti's crystalline dystrophy." This patent describes a vector comprising a polynucleotide encoding CYP4V2 and a promoter operably linked to the polynucleotide. The vector demonstrates a good expression effect, high expression speed, and stable expression intensity. Additionally, the application provides cells, pharmaceutical compositions, and kits that utilize the vector, along with methods for treating, alleviating, and preventing diseases associated with retinal pigment epithelium (RPE) atrophy.

Career Highlights

Ruixuan Jia is associated with Chigenovo Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for retinal disorders, showcasing his commitment to improving patient outcomes.

Collaborations

Ruixuan has collaborated with notable colleagues, including Liping Yang and Shaohong Chen, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the field of gene therapy.

Conclusion

Ruixuan Jia's innovative contributions to gene therapy, particularly through his patent for treating Bietti's crystalline dystrophy, highlight his role as a key figure in advancing medical science. His ongoing work at Chigenovo Co., Ltd. promises to bring new hope to patients suffering from retinal diseases.